[
    [
        {
            "time": "2023-12-07",
            "original_text": "7日晚公告精选丨比亚迪：控股股东王传福拟增持100万股",
            "features": {
                "keywords": [
                    "比亚迪",
                    "王传福",
                    "增持",
                    "100万股"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "汽车制造"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "7日晚公告精选丨比亚迪：控股股东王传福拟增持100万股",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-12-07",
            "original_text": "公告精选：药明康德确定H股发行价为每股68港元；王传福拟增持100万股比亚迪",
            "features": {
                "keywords": [
                    "药明康德",
                    "H股",
                    "发行价",
                    "68港元",
                    "比亚迪",
                    "王传福",
                    "增持"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "汽车制造"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "公告精选：药明康德确定H股发行价为每股68港元；王传福拟增持100万股比亚迪",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-12-13",
            "original_text": "药明康德：H股发行价格为每股68港元 将于12月13日香港上市",
            "features": {
                "keywords": [
                    "药明康德",
                    "H股",
                    "发行价格",
                    "68港元",
                    "香港上市"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "药明康德：H股发行价格为每股68港元 将于12月13日香港上市",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-12-13",
            "original_text": "药明康德：H股发行价定为68港元，12月13日登陆港交所",
            "features": {
                "keywords": [
                    "药明康德",
                    "H股",
                    "发行价",
                    "68港元",
                    "港交所"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "药明康德：H股发行价定为68港元，12月13日登陆港交所",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-12-13",
            "original_text": "药明康德港股IPO定价68港元",
            "features": {
                "keywords": [
                    "药明康德",
                    "港股",
                    "IPO",
                    "定价",
                    "68港元"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "药明康德港股IPO定价68港元",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        }
    ]
]